C. James, V. Ugo, L. Couedic, J. Staerk, J. Delhommeau et al., A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera, Nature, vol.100, issue.7037, pp.1144-1152, 2005.
DOI : 10.1182/blood-2002-09-2839

E. Baxter, L. Scott, P. Campbell, C. East, N. Fourouclas et al., Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders, The Lancet, vol.365, issue.9464, pp.1054-61, 2005.
DOI : 10.1016/S0140-6736(05)74230-6

R. Kralovics, F. Passamonti, A. Buser, S. Teo, R. Tiedt et al., in Myeloproliferative Disorders, New England Journal of Medicine, vol.352, issue.17, pp.1779-90, 2005.
DOI : 10.1056/NEJMoa051113

R. Levine, M. Wadleigh, J. Cools, B. Ebert, G. Wernig et al., Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis, Cancer Cell, vol.7, issue.4, pp.387-97, 2005.
DOI : 10.1016/j.ccr.2005.03.023

E. Lippert, M. Boissinot, R. Kralovics, F. Girodon, I. Dobo et al., The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera, Blood, vol.108, issue.6, pp.1865-1872, 2006.
DOI : 10.1182/blood-2006-01-013540

C. James, F. Delhommeau, C. Marzac, I. Teyssandier, J. Couedic et al., Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis, Leukemia, vol.106, issue.2, pp.350-353, 2006.
DOI : 10.1038/sj.leu.2404069

A. Tefferi and J. Spivak, Polycythemia Vera: Scientific Advances and Current Practice, Seminars in Hematology, vol.42, issue.4, pp.206-226, 2005.
DOI : 10.1053/j.seminhematol.2005.08.003

A. Tefferi and A. Pardanani, Mutation screening for JAK2V617F: When to order the test and how to interpret the results, Leukemia Research, vol.30, issue.6, pp.739-783, 2006.
DOI : 10.1016/j.leukres.2006.01.004

P. Mossuz, F. Girodon, M. Donnard, V. Latger-cannard, I. Dobo et al., Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis, Haematologica, vol.89, pp.1194-1202, 2004.

M. Percy, F. Jones, A. Green, J. Reilly, and M. Mcmullin, The incidence of the JAK2 V617F mutation in patients with idiopathic erythrocytosis, Haematologica, vol.91, pp.413-417, 2006.